T1	CHEM 46 57	Resveratrol
#1	AnnotatorNotes T1	C0073096; resveratrol; Organic Chemical · Pharmacologic Substance
T2	PROC 63 85	tratamiento preventivo
#2	AnnotatorNotes T2	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T3	DISO 90 127	Síndrome de Hiperestimulación Ovárica
#3	AnnotatorNotes T3	C0085083; Ovarian Hyperstimulation Syndrome; Disease or Syndrome
T4	PROC 150 230	Ensayo clínico randomizado contra placebo, prospectivo, unicéntrico, doble-ciego
T5	PROC 826 845	Número de folículos
#5	AnnotatorNotes T5	C3273281; Antral follicle count; Diagnostic Procedure
T6	PROC 1025 1045	donación de ovocitos
#6	AnnotatorNotes T6	C0242813; Oocyte Donation; Therapeutic or Preventive Procedure
T7	CHEM 258 269	resveratrol
#7	AnnotatorNotes T7	C0073096; resveratrol; Organic Chemical · Pharmacologic Substance
T8	PROC 275 297	tratamiento preventivo
#8	AnnotatorNotes T8	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T9	DISO 1130 1133	VHB
#9	AnnotatorNotes T9	C0019163; Hepatitis B; Disease or Syndrome
T10	DISO 302 339	síndrome de hiperestimulación ovárica
#10	AnnotatorNotes T10	C0085083; Ovarian Hyperstimulation Syndrome; Disease or Syndrome
T11	CHEM 363 374	Resveratrol
#11	AnnotatorNotes T11	C0073096; resveratrol; Organic Chemical · Pharmacologic Substance
T12	PROC 381 389	prevenir
#12	AnnotatorNotes T12	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T13	DISO 1135 1138	VHC
#13	AnnotatorNotes T13	C0019196; Hepatitis C; Disease or Syndrome
T14	DISO 409 446	síndrome de hiperestimulación ovárica
#14	AnnotatorNotes T14	C0085083; Ovarian Hyperstimulation Syndrome; Disease or Syndrome
T15	CHEM 474 485	Resveratrol
#15	AnnotatorNotes T15	C0073096; resveratrol; Organic Chemical · Pharmacologic Substance
T16	PROC 492 500	prevenir
#16	AnnotatorNotes T16	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T17	DISO 520 557	síndrome de hiperestimulación ovárica
#17	AnnotatorNotes T17	C0085083; Ovarian Hyperstimulation Syndrome; Disease or Syndrome
T18	CHEM 599 603	VEGF
#18	AnnotatorNotes T18	C117189; VEGF protein, human; Amino Acid, Peptide, or Protein · Biologically Active Substance | C1256770; Vascular Endothelial Growth Factors; Amino Acid, Peptide, or Protein · Biologically Active Substance
T19	CHEM 606 615	estradiol
#19	AnnotatorNotes T19	C0014912; estradiol; Hormone · Organic Chemical · Pharmacologic Substance
T20	DISO 630 647	hemoconcentración
#20	AnnotatorNotes T20	C0854379; Haemoconcentration; Finding
T21	ANAT 764 772	ovocitos
#21	AnnotatorNotes T21	C0029045; Oocytes; Cell
T22	ANAT 836 845	folículos
#22	AnnotatorNotes T22	C0018120; Ovarian Follicle; Body Part, Organ, or Organ Component | C1571705; Follicle; Body Part, Organ, or Organ Component
T23	PROC 872 881	ecografía
#23	AnnotatorNotes T23	C0041618; Ultrasonography; Diagnostic Procedure
T24	ANAT 936 944	ovocitos
#24	AnnotatorNotes T24	C0029045; Oocytes; Cell
T25	ANAT 1037 1045	ovocitos
#25	AnnotatorNotes T25	C0029045; Oocytes; Cell
T26	DISO 1057 1060	SOP
#26	AnnotatorNotes T26	C0032460; Polycystic Ovary Syndrome; Disease or Syndrome
T27	DISO 1062 1075	endometriosis
#27	AnnotatorNotes T27	C0014175; Endometriosis; Disease or Syndrome
T28	PROC 1104 1114	serologías
#28	AnnotatorNotes T28	C0036743; Serologic tests; Laboratory Procedure
T29	DISO 1146 1164	cariotipo alterado
#29	AnnotatorNotes T29	C0476431; Abnormal Karyotype; Finding
T30	ANAT 120 127	Ovárica
#30	AnnotatorNotes T30	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T31	ANAT 332 339	ovárica
#31	AnnotatorNotes T31	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T32	ANAT 439 446	ovárica
#32	AnnotatorNotes T32	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T33	ANAT 550 557	ovárica
#33	AnnotatorNotes T33	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T34	ANAT 678 694	líquido ascítico
#34	AnnotatorNotes T34	C0003964; Peritoneal Fluid (body substance); Body Substance
T35	PROC 896 921	inducción de la ovulación
#35	AnnotatorNotes T35	C0029967; Ovulation Induction; Therapeutic or Preventive Procedure
T36	DISO 1077 1096	patología sistémica
T37	DISO 1141 1144	VIH
#36	AnnotatorNotes T37	C0458074; Human immunodeficiency virus (HIV) status; Finding
T38	Date 13 17	2014
T41	LIVB 752 772	Donantes de ovocitos
#37	AnnotatorNotes T41	C3267027; Oocyte donor; Population Group
T43	PHYS 912 921	ovulación
#38	AnnotatorNotes T43	C0029965; Ovulation; Organ or Tissue Function
T45	Age 1047 1055	>35 años
T39	PROC 936 956	ovocitos recuperados
#39	AnnotatorNotes T39	C0404268; Oocyte Retrieval; Therapeutic or Preventive Procedure
T40	CONC 926 956	Número de ovocitos recuperados
#4	AnnotatorNotes T40	C0449803; Number of oocytes; Quantitative Concept
T42	Result_or_Value 957 965	> o = 21
R1	Has_Result_or_Value Arg1:T40 Arg2:T42	
T44	Result_or_Value 847 854	> 12 mm
R2	Has_Result_or_Value Arg1:T22 Arg2:T44	
T46	Result_or_Value 857 865	> o = 21
R3	Has_Result_or_Value Arg1:T5 Arg2:T46	
R4	Overlap Arg1:T23 Arg2:T35	
R5	Overlap Arg1:T5 Arg2:T23	
R6	Used_for Arg1:T1 Arg2:T2	
R7	Location_of Arg1:T30 Arg2:T3	
R8	Location_of Arg1:T32 Arg2:T14	
R9	Location_of Arg1:T33 Arg2:T17	
R10	Location_of Arg1:T31 Arg2:T10	
R11	Used_for Arg1:T7 Arg2:T8	
T47	Observation 247 253	efecto
#40	AnnotatorNotes T47	C1518681; Outcome of Therapy; Finding (?)
R12	Causes Arg1:T7 Arg2:T47	
R13	Used_for Arg1:T11 Arg2:T12	
R14	Used_for Arg1:T15 Arg2:T16	
R15	Before Arg1:T12 Arg2:T14	
R16	Before Arg1:T16 Arg2:T17	
R19	Before Arg1:T35 Arg2:T43	
T51	Quantifier_or_Qualifier 1097 1102	grave
#44	AnnotatorNotes T51	C1547227; Severe - Severity of Illness Code; Intellectual Product
R20	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T51	
#45	AnnotatorNotes T36	C0442893; Systemic disease; Disease or Syndrome
T52	Result_or_Value 1115 1124	positivas
#46	AnnotatorNotes T52	C1446409; Positive; Finding
R21	Has_Result_or_Value Arg1:T28 Arg2:T52	
R22	Before Arg1:T2 Arg2:T3	
R23	Before Arg1:T8 Arg2:T10	
A1	Experiencer T41 Patient
